195 related articles for article (PubMed ID: 10962364)
21. Diffuse hypertrichosis during treatment with 5% topical minoxidil.
Peluso AM; Misciali C; Vincenzi C; Tosti A
Br J Dermatol; 1997 Jan; 136(1):118-20. PubMed ID: 9039309
[TBL] [Abstract][Full Text] [Related]
22. A multicenter, randomized, placebo-controlled, double-blind clinical trial of a novel formulation of 5% minoxidil topical foam versus placebo in the treatment of androgenetic alopecia in men.
Olsen EA; Whiting D; Bergfeld W; Miller J; Hordinsky M; Wanser R; Zhang P; Kohut B
J Am Acad Dermatol; 2007 Nov; 57(5):767-74. PubMed ID: 17761356
[TBL] [Abstract][Full Text] [Related]
23. Excellent response to mesotherapy as adjunctive treatment in male androgenetic alopecia.
Melo DF; de Mattos Barreto T; Plata GT; Araujo LR; Tortelly VD
J Cosmet Dermatol; 2020 Jan; 19(1):75-77. PubMed ID: 31066492
[TBL] [Abstract][Full Text] [Related]
24. Comparison of the efficacy and safety of topical minoxidil and topical alfatradiol in the treatment of androgenetic alopecia in women.
Blume-Peytavi U; Kunte C; Krisp A; Garcia Bartels N; Ellwanger U; Hoffmann R
J Dtsch Dermatol Ges; 2007 May; 5(5):391-5. PubMed ID: 17451383
[TBL] [Abstract][Full Text] [Related]
25. Efficacy and safety of very-low-dose oral minoxidil 1.25 mg in male androgenetic alopecia.
Jha AK; Sonthalia S; Zeeshan MD; Vinay K
J Am Acad Dermatol; 2020 Nov; 83(5):1491-1493. PubMed ID: 32492469
[No Abstract] [Full Text] [Related]
26. Effectiveness and safety of low-dose oral minoxidil in male androgenetic alopecia.
Jimenez-Cauhe J; Saceda-Corralo D; Rodrigues-Barata R; Hermosa-Gelbard A; Moreno-Arrones OM; Fernandez-Nieto D; Vaño-Galvan S
J Am Acad Dermatol; 2019 Aug; 81(2):648-649. PubMed ID: 31054970
[No Abstract] [Full Text] [Related]
27. [Minoxidil--a hope for patients with androgen alopecia?].
Mørk C; Braathen LR
Tidsskr Nor Laegeforen; 1988 Oct; 108(28):2391-3. PubMed ID: 3061060
[No Abstract] [Full Text] [Related]
28. Oral Drug as Effective as Topical Cream for Male Pattern Baldness.
Harris E
JAMA; 2024 May; 331(20):1698. PubMed ID: 38700895
[No Abstract] [Full Text] [Related]
29. Case series of oral minoxidil for androgenetic and traction alopecia: Tolerability & the five C's of oral therapy.
Beach RA
Dermatol Ther; 2018 Nov; 31(6):e12707. PubMed ID: 30246901
[No Abstract] [Full Text] [Related]
30. Male pattern androgenetic alopecia.
Sinclair R
BMJ; 1998 Sep; 317(7162):865-9. PubMed ID: 9748188
[No Abstract] [Full Text] [Related]
31. [Drug treatment of alopecia].
Wolff H
Internist (Berl); 2015 Oct; 56(10):1196-208. PubMed ID: 26383761
[TBL] [Abstract][Full Text] [Related]
32. Androgenetic alopecia: overview.
Sawaya ME
J Cutan Med Surg; 1999 Nov; 3 Suppl 3():S14-20. PubMed ID: 11749885
[No Abstract] [Full Text] [Related]
33. Advances in the treatment of male androgenetic alopecia: a brief review of finasteride studies.
Whiting DA
Eur J Dermatol; 2001; 11(4):332-4. PubMed ID: 11399540
[TBL] [Abstract][Full Text] [Related]
34. [Drug treatment of androgenetic alopecia in men].
Wolff H; Kunte C
Pharm Unserer Zeit; 2000 May; 29(3):153-8. PubMed ID: 10881599
[No Abstract] [Full Text] [Related]
35. Topical minoxidil therapy for androgenetic alopecia.
Epstein E
Arch Dermatol; 1988 Mar; 124(3):322-3. PubMed ID: 3345081
[No Abstract] [Full Text] [Related]
36. Treatment of female pattern hair loss with a combination of spironolactone and minoxidil.
Hoedemaker C; van Egmond S; Sinclair R
Australas J Dermatol; 2007 Feb; 48(1):43-5. PubMed ID: 17222303
[TBL] [Abstract][Full Text] [Related]
37. Long-term treatment with finasteride 1 mg decreases the likelihood of developing further visible hair loss in men with androgenetic alopecia (male pattern hair loss).
Kaufman KD; Rotonda J; Shah AK; Meehan AG
Eur J Dermatol; 2008; 18(4):400-6. PubMed ID: 18573712
[TBL] [Abstract][Full Text] [Related]
38. A randomized, placebo-controlled trial of 1% topical minoxidil solution in the treatment of androgenetic alopecia in Japanese women.
Tsuboi R; Tanaka T; Nishikawa T; Ueki R; Yamada H; Katsuoka K; Ogawa H; Takeda K
Eur J Dermatol; 2007; 17(1):37-44. PubMed ID: 17324826
[TBL] [Abstract][Full Text] [Related]
39. Evaluation of sexual function with an international index of erectile function in subjects taking finasteride for androgenetic alopecia.
Tosti A; Pazzaglia M; Soli M; Rossi A; Rebora A; Atzori L; Barbareschi M; Benci M; Voudouris S; Vena GA
Arch Dermatol; 2004 Jul; 140(7):857-8. PubMed ID: 15262698
[TBL] [Abstract][Full Text] [Related]
40. [Efficacy and cardiovascular tolerability of minotricon in the treatment of seborrheic alopecia].
Rigoni C; Pinelli S; Toffolo P; Scarabelli G; Terenzio C
G Ital Dermatol Venereol; 1990 Oct; 125(10):XLVII-LIII. PubMed ID: 2150507
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
